Cancellation of state registration. Timololong®

December 07, 2016
Active substances:
Trade names:
ICD-10:
VI.G40-G47.G43    Migraine
VII.H40-H42.H40.5    Glaucoma secondary due to other eye diseases
VII.H40-H42.H40.4    Glaucoma secondary due to inflammatory disease of the eye
VII.H40-H42.H40.3    Glaucoma secondary posttraumatic
VII.H40-H42.H40.2    Primary angle-closure glaucoma
VII.H40-H42.H40.1    Primary open angle glaucoma
VII.H40-H42.H40.0    Suspicion of glaucoma
IX.I10-I15.I10    Essential [primary] hypertension
IX.I20-I25.I20    Angina pectoris [angina pectoris]
IX.I20-I25.I21    Acute myocardial infarction
Timololong, timolol, antiglaucoma, glaucoma treatment, increased intraocular pressure

The Ministry of Health of the Russian Federation in accordance with articles 29 and 32 of the Federal Law of 12.04.2010 No. 61-FZ "On circulation of medicines" decided to abolish state registration and exclusion from the state register of medicinal products for medical use of the medicinal product (registration certificate LP- 000917 dated October 18, 2011, closed Joint-Stock Company "Firn M" (ZAO "Firn M"), Russia):

Timololong® (trade name of the medicinal product)

Timolol (international non-proprietary, or grouping, or chemical name medicinal product)

eye drops, 0.25%, 0.5% (dosage form, dosage)

Closed Joint Stock Company "Firn M" (ZAO "Firn M"), Russia 143390, Moscow, dn. Kokoshkino, Dzerzhinsky, 4 (name and address of the place of production)

in connection with the non-confirmation of the state registration of the medicinal product for medical use according to the results of the examination of the relationship between the expected benefit and the possible risk of drug use.